The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy
- Conditions
- refractory epilepsy patients
- Registration Number
- JPRN-UMIN000025090
- Lead Sponsor
- Yokohama City University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 8
Not provided
1.patients who have significant abnormalities insides the brains 2.patients who have experienced the electric stimulation therapy 3.patients who undergo artificial dialysis 4.patients who have severe liver dysfunction 5.patients who have tatoo 6.claustrophobic patients 7.breast-feeding mothers, expecting mothers, females who desire to be a mother 8.patients who desire to bear a child within this study period 9.patients who take Fycompa 10.patients who underwent nuclear medicine examination within one-week before this registarion 11.patients who underwent other clinical trials using unapproved nuclear medicine examination within six month before this registarion 12.patients who underwent other clinical trials within 12 weeks before this registarion 13.patients whom study doctors consider unappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation of the AMPA receptors densities examined by biochemical study and [11C]K-2 PET study
- Secondary Outcome Measures
Name Time Method The adverse events occured in patients during 7days after PET scan